Elke Birkemeyer

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study.

H. Sorbye, E. Hofsli, H. Grønbaek, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study.

H. Sorbye, E. Kure, E. Skovlund, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer.

Lars Påhlman, Bengt Glimelius, L. Påhlman, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy

O. Nordgård, Satu Oltedal, O. G. Aasprong, 2011, International Journal of Colorectal Disease.